Devyser Diagnostics AB (publ) (DVYSR.ST)

SEK 117.0

(0.0%)

Inventory Summary of Devyser Diagnostics AB (publ)

Devyser Diagnostics AB (publ)'s latest annual inventory in 2023 was 20.6 Million SEK , up 100.31% from previous year.
Devyser Diagnostics AB (publ)'s latest quarterly inventory in 2024 Q2 was 26.3 Million SEK , up 6.91% from previous quarter.
Devyser Diagnostics AB (publ) reported annual inventory of 10.28 Million SEK in 2022, up 48.06% from previous year.
Devyser Diagnostics AB (publ) reported annual inventory of 6.94 Million SEK in 2021, up 27.5% from previous year.
Devyser Diagnostics AB (publ) reported quarterly inventory of 26.3 Million SEK for 2024 Q2, up 6.91% from previous quarter.
Devyser Diagnostics AB (publ) reported quarterly inventory of 24.6 Million SEK for 2024 Q1, up 19.42% from previous quarter.

Annual Inventory Chart of Devyser Diagnostics AB (publ) (2023 - 2018)

Historical Annual Inventory of Devyser Diagnostics AB (publ) (2023 - 2018)

Year	Inventory	Inventory Growth
2023	20.6 Million SEK	100.31%
2022	10.28 Million SEK	48.06%
2021	6.94 Million SEK	27.5%
2020	5.44 Million SEK	40.88%
2019	3.86 Million SEK	-6.25%
2018	4.12 Million SEK	0.0%

Year	Inventory	Inventory Growth
2024 Q3	24.6 Million SEK	-6.46%
2024 Q2	26.3 Million SEK	6.91%
2024 Q1	24.6 Million SEK	19.42%
2023 FY	20.6 Million SEK	100.31%
2023 Q4	20.6 Million SEK	31.21%
2023 Q3	15.7 Million SEK	6.08%
2023 Q2	14.8 Million SEK	39.62%
2023 Q1	10.6 Million SEK	3.07%
2022 Q1	8.7 Million SEK	25.25%
2022 Q3	9 Million SEK	1.12%
2022 Q2	8.9 Million SEK	2.3%
2022 Q4	10.28 Million SEK	14.27%
2021 Q4	6.94 Million SEK	0.0%

Peer Inventory Comparison of Devyser Diagnostics AB (publ)

Name	Inventory	Inventory Difference
AroCell AB (publ)	6.07 Million SEK	-239.318%
Immunovia AB (publ)	1.00 SEK	-2059999900.0%
Prostatype Genomics AB (publ)	203 Thousand SEK	-10047.783%
SenzaGen AB	6.22 Million SEK	-230.764%
Spermosens AB	-232 Thousand SEK	8979.31%